RAWALPINDI — Pharmaceutical traders in Rawalpindi have expressed strong approval of the federal budget for the fiscal year 2026-27, focusing on the relief measures targeting medicines and taxation.
Abolition of Federal Excise Duty
The government has abolished the Federal Excise Duty (FED) on essential medicines, particularly for severe illnesses like cancer. This decision has garnered significant support from the pharmaceutical sector.
Effect on Patients
Faizan Malik, a local trader, highlighted that this change will ease the financial burden on patients and improve access to necessary medications. These relief measures are anticipated to benefit pharmacy traders by making medicines more affordable and boosting demand.
Maintaining Stability in Pharmaceutical Taxation
Malik discussed the critical importance of stable taxation within the pharmaceutical industry. Such stability is vital for ensuring a continuous supply and fair pricing of medications.
Advantages of a Pro-Public Budget
Another trader, Khurram, shared similar views, commending the budget’s pro-public stance, particularly in the health sector. The removal of FED on crucial medicines reduces healthcare costs for patients with life-threatening conditions.
Khurram also emphasized the necessity for consistent policy implementation and ongoing support to strengthen the healthcare supply chain.
